Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Dermatologic 1

Conditions

Melanoma 147Carcinoma, Non-Small-Cell Lung 34Skin Neoplasms 28Colorectal Neoplasms 28Breast Neoplasms 25Lung Neoplasms 24Carcinoma, Renal Cell 21Ovarian Neoplasms 20Neoplasms 20Squamous Cell Carcinoma of Head and Neck 19Carcinoma, Basal Cell 19Carcinoma, Merkel Cell 18Sarcoma 17Prostatic Neoplasms 17Pancreatic Neoplasms 16Neoplasm Metastasis 15Head and Neck Neoplasms 14Stomach Neoplasms 13Thyroid Neoplasms 12Uterine Cervical Neoplasms 11Urinary Bladder Neoplasms 11Carcinoma, Hepatocellular 11Lymphoma, T-Cell, Cutaneous 10Esophageal Neoplasms 10Carcinoma, Transitional Cell 9Uveal Melanoma 8Triple Negative Breast Neoplasms 8Mycosis Fungoides 8Colonic Neoplasms 8Small Cell Lung Carcinoma 7

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Crohn Disease × Dermatologic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡